Is Alphabet an Undervalued Growth Stock to Buy?
Alphabet (NASDAQ:GOOGL) is easily one of the most successful companies…
Buy
59
SMLR Quote, Financials, Valuation and Earnings
Last price:
$65.60
Seasonality move
:
7.51%
Day range:
$59.02 - $63.67
52-week range:
$20.88 - $81.56
Dividend yield:
0%
P/E ratio:
30.06x
P/S ratio:
8.13x
P/B ratio:
5.25x
Volume:
318.4K
Avg. volume:
1.1M
1-year change:
42.7%
Market cap:
$448M
Revenue:
$68.2M
EPS (TTM):
$2.05
Analysts' Opinion
-
Consensus RatingSemler Scientific has received a consensus rating of Buy. The company's average rating is a Buy based on 0 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target DownsideAccording to analysts' consensus price target of --, Semler Scientific has an estimated downside of -35.13% from its current price of $61.66.
-
Price Target UpsideAccording to analysts, the highest upside price target is -- representing -100% upside increase from its current price of $61.66.
Fair Value
-
According to the consensus of 0 analysts, Semler Scientific has -35.13% downside to fair value with a price target of -- per share.
SMLR vs. S&P 500
-
Over the past 5 trading days, Semler Scientific has underperformed the S&P 500 by -18.65% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Semler Scientific does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Semler Scientific revenues have been falling on a year-over-year basis for 3 quarters in a row. In the most recent quarter Semler Scientific reported revenues of $13.5M.
Earnings Growth
-
Semler Scientific has grown year-over-year earnings for 1 quarter straight. In the most recent quarter Semler Scientific reported earnings per share of $0.72.
Enterprise value:
435.4M
EV / Invested capital:
5.10x
Price / LTM sales:
8.13x
EV / EBIT:
21.72x
EV / Revenue:
7.39x
PEG ratio (5yr expected):
0.24x
EV / Free cash flow:
-9.30x
Price / Operating cash flow:
7.77x
Enterprise value / EBITDA:
21.04x
Gross Profit (TTM):
$51.9M
Return On Assets:
19.02%
Net Income Margin (TTM):
27%
Return On Equity:
20.71%
Return On Invested Capital:
20.71%
Operating Margin:
37.49%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Income Statement | ||||||
| Revenue | $54.4M | $66.9M | $58.9M | $16.3M | $13.5M | |
| Gross Profit | $49.2M | $62.1M | $51.9M | $15.2M | $12.4M | |
| Operating Income | $15.3M | $24M | $20M | $6.9M | $5.1M | |
| EBITDA | $15.9M | $24.5M | $20.7M | $7.1M | $5.2M | |
| Diluted EPS | $1.57 | $2.50 | $2.05 | $0.71 | $0.72 | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $21.8M | $46.1M | $51.7M | $64.4M | $21.5M | |
| Total Assets | $28M | $51M | $60.9M | $79.4M | $92.2M | |
| Current Liabilities | $5.7M | $6.7M | $8.4M | $8.6M | $6.8M | |
| Total Liabilities | $6M | $7M | $8.6M | $8.7M | $6.8M | |
| Total Equity | $22.1M | $44M | $52.4M | $70.8M | $85.4M | |
| Total Debt | -- | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $17.4M | $18.6M | $21.4M | $4.8M | $6.4M | |
| Cash From Investing | -$2.8M | -$24.5M | -$50.4M | -$6.8M | -$8.4M | |
| Cash From Financing | -$5.1M | -$2.1M | -$1.9M | -$51K | $1.2M | |
| Free Cash Flow | $15.8M | $16.7M | -$46.8M | $4.7M | -$2M | |
SMLR
Sector
Market Cap
$448M
$45.6M
Price % of 52-Week High
75.61%
45.55%
Dividend Yield
0%
0%
Shareholder Yield
--
-0.74%
1-Year Price Total Return
42.7%
-31.35%
Beta (5-Year)
1.182
0.772
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Sell
Level
$67.27
200-day SMA
Buy
Level
$33.53
Bollinger Bands (100)
Buy
Level
21.26 - 52.78
Chaikin Money Flow
Sell
Level
-9.1M
20-day SMA
Sell
Level
$63.23
Relative Strength Index (RSI14)
Buy
Level
52.52
ADX Line
Sell
Level
19.93
Williams %R
Buy
Level
-82.126
50-day SMA
Buy
Level
$48.01
MACD (12, 26)
Buy
Level
4.53
25-day Aroon Oscillator
Buy
Level
76
On Balance Volume
Neutral
Level
10.5M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (33.0167)
Buy
CA Score
(Annual)
Level (3.2502)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (5)
Buy
Ohlson Score
Level (-9.9673)
Buy
Piotroski F Score
(Annual)
Level (6)
Buy
Quality Ratio Score
Level (7)
Buy
Fundamental Score
Level (6)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Semler Scientific Inc is a United States based company that is engaged in providing technology solutions to improve the clinical effectiveness and efficiency of healthcare providers. It focuses on developing, manufacturing, and marketing proprietary products and services that assist customers, including insurance plans, physicians, and risk assessment groups, in evaluating and treating chronic diseases. The company markets its vascular-testing product under the QuantaFlo brand, which is a four-minute in-office blood flow test.
Stock Forecast FAQ
In the current month, SMLR has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The SMLR average analyst price target in the past 3 months is --.
-
Where Will Semler Scientific Stock Be In 1 Year?
According to analysts, the consensus estimate is that Semler Scientific share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About Semler Scientific?
Analysts are divided on their view about Semler Scientific share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Semler Scientific is a Sell and believe this share price will rise from its current level to --.
-
What Is Semler Scientific's Price Target?
The price target for Semler Scientific over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is SMLR A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Semler Scientific is a Buy. 0 of 0 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of SMLR?
You can purchase shares of Semler Scientific via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Semler Scientific shares.
-
What Is The Semler Scientific Share Price Today?
Semler Scientific was last trading at $65.60 per share. This represents the most recent stock quote for Semler Scientific. Yesterday, Semler Scientific closed at $61.66 per share.
-
How To Buy Semler Scientific Stock Online?
In order to purchase Semler Scientific stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Tesla Going to Buy Uber?
Tesla has always been in the habit of making large,…
NVIDIA vs Broadcom Stock: Which Is Best?
If you want to invest in an AI-leading tech company,…
Stock Ideas
Buy
65
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 42x
Buy
57
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 117x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
73
PSIX alert for Dec 24
Power Solutions International [PSIX] is up 27.42% over the past day.
Sell
40
MSTR alert for Dec 24
MicroStrategy [MSTR] is up 8.07% over the past day.
Sell
26
NUTX alert for Dec 24
Nutex Health [NUTX] is down 1.39% over the past day.
